Skaggs School of Pharmacy and Pharmaceutical Sciences
Dr. Ruben Abagyan is a Professor in the Skaggs School of Pharmacy at the University of California, San Diego, which he joined in 2009. He received his Master’s degree in molecular physics from the Moscow Institute of Physics and Technology and his Ph.D. in molecular modeling and biophysics from the Moscow State University. At the European Molecular Biology Laboratory in Heidelberg he developed internal coordinate mechanics and docking approach (ICM). He built computational biology and chemistry facilities at the Skirball Institute in New York, Novartis Institute in La Jolla, Scripps Research Institute and San Diego Supercomputer Center, founded Molsoft Company, and served on boards of several companies. Currently Dr. Abagyan serves on international review panels for Institutes in Switzerland, UK and Hong Kong. He received two CapCure awards, and Princess Diana Award and medal in Sydney, Australia. R.A. authored and co-authored over 250 research papers and book chapters.
Ruben Abagyan studied physical chemistry and has completed his PhD in biophysics from the Moscow State University. He worked as a researcher, lab head or director of computational departments in a number of research organizations. His research interests include computational structural biology and cheminformatics, with a particular focus on modeling and docking screening, including target identification, polypharmacology and adverse effect prediction, and molecular modeling for G-protein coupled receptors, kinases and nuclear receptors. He has published more than 250 papers and book chapters in research journals and is serving as a number of international review panels and editorial boards.